2.1 与和偏头痛神经发育障碍相关的变体
Ulises Meza1, Catalina Romero-Méndez1, Danira A Ramírez-De León1
1Department of Physiology and Biophysics, School of Medicine, Autonomous University of San Luis Potosí, San Luis Potosí, México.
概括
新的P/Q类通道突变通过改变通道功能引起神经系统障碍. 了解这些CaV2.1通道病是诊断和治疗和偏头痛等疾病的关键.
科学领域:
- 神经科学
- 分子生物学
- 遗传学
背景情况:
- P/Q型CaV2.1通道对于神经递质的释放至关重要.
- CACNA1A中的突变会导致EA2和FHM1等通道病变,通常通过功能损失或增益.
- 最近的研究将CaV2.1点突变与更广泛的神经疾病联系起来.
研究的目的:
- 调查 CaV2.1 新型变体 (V176M 和 R1673C) 对道生物物理学的功能影响.
- 了解这些突变导致神经通道病的独特机制.
- 将分子变化与观察到的通道门变化相关联.
主要方法:
- 在HEK 293细胞中表达了人类CaV2.1变异的鼠标基因组.
- 使用补丁电生理学来分析道的生物物理性质.
- 采用分子建模来预测影响道门的结构变化.
主要成果:
- 这种V178M变种导致激活的超极化转移,并减缓了失活.
- R1624C变种表现出缓慢的激活动力学,延迟的关闭和加速的失活恢复.
- 分子建模表明观察到的门变化背后的结构变化.
结论:
- CaV2.1变种V176M和R1673C的冲击通道通过不同的机制起作用.
- 这些明显的功能变化可能导致患者观察到的各种神经症状.
- 对这些特定突变的进一步研究可以阐明CaV2.1通道病变的病因.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
439
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
439
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.6K
Voltage-gated Ion Channels
8.6K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.6K
Epilepsy and Seizures: Overview
274
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
274
Ligand-gated Ion Channels
12.7K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.7K
Antiepileptic Drugs: GABAergic Pathway Potentiators
632
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
632


